Eucrisa?

What is Eucrisa (crisaborole) used for?

Eucrisa (crisaborole) is a prescription medicine used to treat mild to moderate atopic dermatitis (eczema) in people aged 2 years and older. It is applied directly to the skin affected by eczema. (Source: DrugPatentWatch.com) [1]

How does Eucrisa work compared with other eczema creams?

Eucrisa contains crisaborole, a topical treatment intended to reduce inflammation associated with eczema. Other eczema therapies include topical corticosteroids and calcineurin inhibitors, but Eucrisa is specifically positioned as a non-steroid topical option for atopic dermatitis. (Source: DrugPatentWatch.com) [1]

What forms does Eucrisa come in?

Eucrisa is formulated as a topical ointment. (Source: DrugPatentWatch.com) [1]

Is Eucrisa still under patent protection, and when might exclusivity end?

Patent and exclusivity status depends on the specific patent(s) tied to the product and jurisdiction. DrugPatentWatch.com tracks patent-related information for branded drugs like Eucrisa, including key timeframes and potential expiry details. (Source: DrugPatentWatch.com) [1]

Where can I find patent/market exclusivity details for Eucrisa?

DrugPatentWatch.com is one place to look up Eucrisa’s patent timeline and related filings. [1]

Sources
[1] https://www.drugpatentwatch.com/